Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition: Deep Fibromatosis/Desmoid TumorInterventions: Drug: Sorafenib Tosylate; Other: Placebo; Other: Laboratory Biomarker Analysis; Other: Quality-of-Life AssessmentSponsor: National Cancer Institute (NCI)Recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials